Effect of Transcranial Neuromodulation (TN) associated with a program based on meditation on the pain of women with Migraine
- Conditions
- Migraine Disorders. Migraine without Aura. Migraine with AuraC23.888.592.612.441
- Registration Number
- RBR-2md8855
- Lead Sponsor
- Centro de Ciências da Saúde da Universidade Federal do Espírito Santo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Women (cis or trans). Aged between 18 and 65 years old. Present a diagnosis of Migraine according to the criteria of The International Classification of Headache Disorders (ICHD-3) 2018, for more than 3 months: at least five attacks meeting criteria from B to D; headache attacks lasting 4-72 hours (without treatment or with ineffective treatment); the headache has at least two of the following characteristics: unilateral location, pulsatile character, moderate or severe pain intensity, exacerbated by or causing the individual to avoid routine physical activities (for example: walking or climbing stairs); during headache, at least one of the following: nausea and/or vomiting, and photophobia and phonophobia, not better explained by another ICHD-3 diagnosis
Participants who are at a peak of cardiovascular disease or have severe cardiopulmonary disease. With sequelae of neurological diseases. Use walking aids. With visual and hearing impairments. With amputations of lower and upper limbs. With rheumatic diseases in the acute phase. Cancer. Epilepsy. Fractures of the skull, neck or rib cage. Severe osteoporosis. People with a pacemaker or implantable cardioverter defibrillator, epilepsy or who underwent surgery less than 1 year ago. Pregnant or breastfeeding women
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method